Receptors, Tumor Necrosis Factor, Type II
"Receptors, Tumor Necrosis Factor, Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS.
MeSH Number(s)
D12.776.543.750.705.852.760.798
D23.050.301.264.035.910
D23.101.100.110.916
Concept/Terms
Receptors, Tumor Necrosis Factor, Type II- Receptors, Tumor Necrosis Factor, Type II
- Receptors, Tumor Necrosis Factor, Member 1B
- TNF-R2
- TNF-R75
- TNF-RII
- TNFR p75
- Tumor Necrosis Factor Receptor 75
- Tumor Necrosis Factor Receptor 2
- TNFR2
- Tumor Necrosis Factor Receptor Type 2
- Tumor Necrosis Factor Receptor Type II
- Antigens, CD120b
- CD120b Antigens
- TNFRSF1B Receptor
- Receptor, TNFRSF1B
- Tumor Necrosis Factor Receptor Superfamily, Member 1B
- CD 120b Antigen
- 120b Antigen, CD
- Antigen, CD 120b
- CD120b Antigen
- Antigen, CD120b
Below are MeSH descriptors whose meaning is more general than "Receptors, Tumor Necrosis Factor, Type II".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Tumor Necrosis Factor [D12.776.543.750.705.852.760]
- Receptors, Tumor Necrosis Factor, Type II [D12.776.543.750.705.852.760.798]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, CD [D23.050.301.264.035]
- Receptors, Tumor Necrosis Factor, Type II [D23.050.301.264.035.910]
- Biological Markers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, CD [D23.101.100.110]
- Receptors, Tumor Necrosis Factor, Type II [D23.101.100.110.916]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Tumor Necrosis Factor, Type II".
This graph shows the total number of publications written about "Receptors, Tumor Necrosis Factor, Type II" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Tumor Necrosis Factor, Type II" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 8 | 8 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 4 | 4 |
| 2003 | 0 | 4 | 4 |
| 2004 | 2 | 5 | 7 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 5 | 6 |
| 2007 | 1 | 4 | 5 |
| 2008 | 1 | 7 | 8 |
| 2009 | 4 | 4 | 8 |
| 2010 | 1 | 3 | 4 |
| 2011 | 1 | 5 | 6 |
| 2012 | 4 | 2 | 6 |
| 2013 | 6 | 3 | 9 |
| 2014 | 4 | 2 | 6 |
| 2015 | 0 | 2 | 2 |
| 2016 | 5 | 2 | 7 |
| 2017 | 7 | 4 | 11 |
| 2018 | 3 | 2 | 5 |
| 2019 | 6 | 3 | 9 |
| 2020 | 4 | 2 | 6 |
| 2021 | 2 | 4 | 6 |
| 2022 | 2 | 3 | 5 |
Below are the most recent publications written about "Receptors, Tumor Necrosis Factor, Type II" by people in Profiles.
-
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells. Cell Oncol (Dordr). 2023 Feb; 46(1):167-177.
-
Trauma, psychological distress and markers of systemic inflammation among US women: A longitudinal study. Psychoneuroendocrinology. 2022 11; 145:105915.
-
The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy. Cells. 2022 06 17; 11(12).
-
Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. J Exp Med. 2022 05 02; 219(5).
-
Acute Kidney Injury Associates with Long-Term Increases in Plasma TNFR1, TNFR2, and KIM-1: Findings from the CRIC Study. J Am Soc Nephrol. 2022 06; 33(6):1173-1181.
-
A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer. Int Immunopharmacol. 2021 Dec; 101(Pt A):108345.
-
Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study. Am J Kidney Dis. 2022 06; 79(6):849-857.e1.
-
Disordered glycemic control in women with type 2 diabetes is associated with increased TNF receptor-2 levels. J Diabetes Complications. 2021 09; 35(9):107974.
-
Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus. J Infect Dis. 2021 05 20; 223(9):1621-1630.
-
Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation. Arthritis Rheumatol. 2021 06; 73(6):970-979.